Target intelligence / Profile preview

Caffeic acid (CA)

Target
CA
Molecular classification
Hydroxycinnamic acid, Polyphenol, Phenylpropanoid
01

Overview

Caffeic acid is a naturally occurring organic compound classified as a hydroxycinnamic acid and a polyphenol, found abundantly in coffee, fruits, and vegetables [1]. It is important to clarify that Caffeic acid is a small molecule metabolite and a dietary phytochemical rather than a traditional therapeutic target like a receptor or enzyme [1, 2]. Biologically, it is renowned for its potent antioxidant properties, which it exerts by scavenging reactive oxygen species and chelating transition metals [2, 3]. It also possesses significant anti-inflammatory activity by inhibiting key enzymes such as cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) [3, 4]. Furthermore, Caffeic acid modulates various intracellular signaling pathways, including the activation of the Nrf2 antioxidant response and the inhibition of the pro-inflammatory NF-κB pathway [4, 5]. These multi-targeted effects contribute to its potential protective roles against chronic diseases such as cancer, cardiovascular disorders, and neurodegenerative conditions [5, 6]. Despite its therapeutic potential, its clinical application is often limited by low oral bioavailability and rapid metabolism [6]. Research continues to explore its derivatives and delivery systems to enhance its efficacy in clinical settings [5].

Other names
3,4-Dihydroxycinnamic acid(E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acidCaffeate
02

Mechanism of action

Caffeic acid acts as an antioxidant by scavenging free radicals and inhibiting enzymes such as cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) [2, 3]. It also modulates signaling pathways like NF-κB and Nrf2 to reduce oxidative stress and inflammation [4, 5].

03

Biological functions

Antioxidant activityAnti-inflammatory responseImmunomodulationInhibition of lipid peroxidationFree radical scavenging
04

Disease associations

CancerInflammationDiabetes mellitusNeurodegenerative diseaseCardiovascular disease
05

Safety considerations

Iron chelationLow oral bioavailabilityPotential pro-oxidant activity at high doses
06

Biomarkers

MalondialdehydeC-reactive proteinInterleukin-6Tumor necrosis factor-alpha

Beyond the preview

Go deeper on Caffeic acid (CA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Caffeic acid (CA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call